(D-ALA2 N-ME-PHE4 MET(O)5-OL) ENKEPHALIN

Base Information

• Chemical Name: (D-ALA2 N-ME-PHE4 MET(O)5-OL) ENKEPHALIN
• CAS No.: 64854-64-4
• Molecular Formula: C29H41 N5 O7 S
• Molecular Weight: 603.74
• Mol file: 64854-64-4.mol

Synonyms:L-Phenylalaninamide,L-tyrosyl-D-alanylglycyl-N-[1-(hydroxymethyl)-3-(methylsulfinyl)propyl]-Na-methyl-, (1S)-;D-Ala2,MePhe4,Met5(O)]enkephalinol;DAMME;FK 33-824;FK 33824;SAN 33-824;Sandoz 33-824;Sandoz FK 33-824;[D-Ala2,N-methyl-Phe4,Met-(O)5-ol]-enkephalin;

Chemical Property of (D-ALA2 N-ME-PHE4 MET(O)5-OL) ENKEPHALIN

Chemical Property:

• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.607
• Boiling Point: 1033.4°Cat760mmHg
• Flash Point: 578.8°C
• Density: 1.302g/cm³
• Storage Temp.: −20°C

Purity/Quality:

98%Min ^*data from raw suppliers

(D-Ala2,N-Me-Phe4,methionin(O)-ol5)-Enkephalin trifluoroacetate salt H-Tyr-D-Ala-Gly-N-Me-Phe-methionin(O)-ol trifluoroacetate salt ^*data from reagent suppliers

Safty Information:

• Pictogram(s):  
• Hazard Codes: 

MSDS Files:

SDS file from LookChem

Useful:

• Uses: (D-Ala2,N-Me-Phe4,methionin(O)-ol5)-Enkephalin Trifluoroacetate Salt H-Tyr-D-Ala-Gly-N-Me-Phe-Methionin(O)-ol Trifluoroacetate Salt used in preparation of opioid peptide-endocannabinoid conjugates for treatment of neuronal disorders.

Technology Process of (D-ALA2 N-ME-PHE4 MET(O)5-OL) ENKEPHALIN

There total 1 articles about (D-ALA2 N-ME-PHE4 MET(O)5-OL) ENKEPHALIN which guide to synthetic route it. The literature collected by LookChem mainly comes from the sharing of users and the free literature resources found by Internet computing technology. We keep the original model of the professional version of literature to make it easier and faster for users to retrieve and use. At the same time, we analyze and calculate the most feasible synthesis route with the highest yield for your reference as below:

synthetic route:

Reference yield:

→ [D-Ala(2), MePhe(4), Met(o)ol(5)]-enkephalin (64854-64-4)

Guidance literature:

Z-Tyr-D-Ala-Gly: 1) MePhe-Met(O)-ol 2) H2-Pd;

DOI:10.1007/BF00405135